Discrimination method of target base in DNA, and allele...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091100

Reexamination Certificate

active

07396648

ABSTRACT:
An object of the present invention is to provide an allele specific primer which is accompanied by less possibility of the false positive and enables definite discrimination when a base immediately adjacent to on the 3′ side of a target SNP base is G, while a base adjacent with one base spaced apart is G. According to the present invention, the 3′ end base is designed to be the base corresponding to SNP; the second base from the 3′ end to be T or G; the third base from the 3′ end to be any one of T or G; and the base sequence of from the fourth from the 3′ end to the 5′ end base to be completely complementary to the sequence of from a base three bases away from the target SNP base on the 3′ side to a desired base.

REFERENCES:
patent: 6750018 (2004-06-01), Kambara et al.
patent: 6794133 (2004-09-01), Ausubel et al.
patent: 2003/0049628 (2003-03-01), Kambara et al.
patent: 2003/0148301 (2003-08-01), Aono et al.
patent: 2003/0186314 (2003-10-01), Kambara et al.
patent: 2004/0197803 (2004-10-01), Yaku et al.
patent: 2002-101899 (2002-04-01), None
patent: 2004-248635 (2004-09-01), None
patent: 2005-065688 (2005-03-01), None
patent: WO 9940219 (1999-08-01), None
patent: WO 01/42498 (2001-06-01), None
Okimoto et al. (“Improved PCR amplification of multiple specific alleles (PAMSA) using internally mismatched primers” Biotechniques. Jul. 1996;21(1):20-2,24,26).
Okano et al. (“Characteristics of selective polymerase chain reaction (PCR) using two-base anchored primers and improvement of its specificity” Electrophoresis. Dec. 1998;19(18):3071-8).
Delrio-Lafreniere et al. (“Simultaneous allele-specific amplification: a strategy using modified primer-template mismatches for SNP detection—application to prothrombin 20210A (factor II) and factor V Leiden (1691A) gene mutations” Mol Diagn. Sep. 2001; 6(3):201-9).
U.S Office Action issued in corresponding U.S. Appl. No. 11/633,584, mailed Jun. 22, 2007.
U.S. Office Action issued in corresponding U.S. Appl. No. 11/471;646, mailed Jun. 26, 2007.
Delrio-Lafreniere et al., “Simultaneous Allele-specific Amplification: A Strategy Using Modified Primer-template Mismatches for SNP Detection-Application to Prothrombin 20210A (Factor II) and Factor V Leiden (1691A) Gene Mutations,” Molecular Diagnosis vol. 6, No. 3, pp. 201-209, 2001, Minneapolis, Minnesota.
U.S. Appl. No. 11/333,352, filed Jan. 18, 2006, Yaku et al.
U.S. Appl. No. 11/203,417, filed Aug. 15, 2005, Yaku et al.
U.S. Appl. No. 11/471,646, filed Jun. 21, 2006, Yaku et al.
U.S. Appl. No. 11/363,953, filed Mar. 1, 2006, Yaku et al.
U.S. Appl. No. 11/489.582, filed Jul. 20, 2006, Yaku et al.
U.S. Appl. No. 11/488,633, filed Jul. 19, 2006, Yaku et al.
U.S. Appl. No. 11/489,583, filed Jul. 20, 2006, Yaku et al.
U.S. Appl. No. 11/633,587, filed Dec. 5, 2006, Yaku et al.
U.S. Appl. No. 11/633,584, filed Dec. 5, 2006, Yaku et al.
U.S. Appl. No. 11/607,907, filed Dec. 4, 2006, Yaku et al.
U.S. Appl. No. 11/488,635, filed Jul. 19, 2006, Yaku et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Discrimination method of target base in DNA, and allele... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Discrimination method of target base in DNA, and allele..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Discrimination method of target base in DNA, and allele... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2743248

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.